Pathological lies: who will be harmed by the regulation of medical congresses
The State Duma adopted in the first reading a bill that should stop the practice of holding promotional events for medical and pharmaceutical companies under the guise of scientific congresses and forums. It is proposed to put them under the control of Roszdravnadzor, as well as to define strict rules: the organizers will be forbidden to give gifts to doctors, give them medicines to distribute to patients and recommend prescribing drugs, etc. It was decided to tighten the holding of congresses after an unsuccessful attempt to hold the organizers of two such forums accountable. However, the new rules for conducting scientific events may also affect real medical events. Details can be found in the Izvestia article.
What is the essence of the bill?
The inter-factional bill was adopted in the first reading at the plenary session on Tuesday. It is emphasized that the document is aimed at protecting the rights and health of citizens "from the actions of unscrupulous organizations when conducting advertising campaigns for medical and pharmaceutical events under the guise of scientific activity."
The concept of a "medical or pharmaceutical scientific event" will be introduced into the legislation, and requirements for its organization will appear. The main one is the need to coordinate the holding of such an event with Roszdravnadzor. In addition, the organizers are going to be banned from distributing false advertising under the guise of a medical or pharmaceutical scientific event, and it will also be impossible to give medicines to doctors for subsequent distribution to patients.
Leonid Ogul, First deputy chairman of the State Duma Committee on Health Protection, said at a meeting of the State Duma that the document had already passed many approvals. According to him, the lack of a definition of a scientific event allows "unscrupulous entrepreneurs to abuse the trust of citizens." The authors of the bill believe that the practice in which commercial structures carry out medical manipulations under the guise of false representatives leads not only to consumer deception, but also to health complications.
At the same time, Roszdravnadzor previously reported that it plans to charge fees from organizers of medical and pharmaceutical events. These funds will finance the examination of programs and the costs of issuing permits. Moreover, the head of the federal service, Anna Samoilova, said that a large number of such events would require an increase in the department's staff.
How many medical forums are there in Russia
Marketing and Development Director of Eurokappa (medical congress organizer company) Anastasia Logova told Izvestia that in 2024, more than 119 thousand notices of scientific events were published in the Roszdravnadzor system, in 2025 - 117 thousand.
According to MedGraf, a company that analyzes the medical educational events market, 6873 events were held in 2025. The peak of the number of such forums, according to analysts, occurred in 2022, when more than 11 thousand of them were held.
Meanwhile, Leonid Ogul told Izvestia that only a small part of the forums and congresses would fall under the new approval requirements.
Exhibitions of companies operating in this market are usually held within the framework of forums, including scientific ones. Each congress has sponsors who make a significant contribution to the budget of the event — they account for 70-90% of the total amount, Anastasia Logova noted.
For example, to become the general sponsor of the Mieloforum, according to the information on the event's website, the company had to pay 1.5 million rubles. Similar prices are available on the Pharma Meeting Point website — from 1.5 to 2 million rubles. Organizations that have invested this amount are offered, among other things, to hold a speech, a marketing campaign for the company and a demonstration of the video on the screen.
Victoria Presnyakova, director of the Association of Independent Pharmacies and head of the Alliance of Pharmaceutical Associations, stressed that there are usually no "random providers" in this market, but the intertwining of scientific and commercial programs at such forums and congresses is "total." The classic financing model is that the manufacturer pays for the participation of its speakers, the rent of the hall, coffee breaks, printing materials, etc.
"In return, he gets a satellite symposium in the main program, hall branding, the opportunity to distribute materials at the counters and access to the lists of registered doctors," the Izvestia interlocutor noted. — Sponsorship of scientific events for pharmaceutical manufacturers, especially domestic ones, is a central element of the drug's market launch and retention strategy. In the context of strict legislative regulation of prescription drug advertising in Russia, the congress remains one of the few legal platforms for direct, concentrated and ethically acceptable communication with the medical and pharmacy communities.
The acceptable boundary between a scientific and commercial program is where "objective information about the mechanisms of action, evidence base, indications and contraindications ends, and direct promotion of a particular brand begins to the detriment of alternatives," added Alexander Dzidzaria, co—chairman of the National Association of Healthcare Managers.
"The Scientific Committee should maintain its independence when forming the program, and sponsorship should be transparently declared," he stressed.
Usually, at major medical congresses, the program is formed by the scientific committee, and vendors only participate in the event with their stands and master classes, but they should not influence the main scientific program, Anastasia Logova clarified.
At the same time, Alexander Dzidzari recalled that such congresses and professional forums play a key role in the system of continuing medical education. There, doctors get access to the results of clinical trials, new treatment protocols, and share practical experience with colleagues from leading centers. And the vast majority of congresses, according to the Izvestia interlocutor, have real scientific content and accreditation in the system of continuing medical education. Although there are events where, under the guise of a scientific school, a presentation of products from one manufacturer is actually held.
What prompted the decision to control the congresses
The authors of the bill in the explanatory note refer to two events that took place in 2025: the International Congress for Cosmetologists and the International Congress for Plastic and Reconstructive Surgeons. According to them, Roszdravnadzor revealed many violations of legislation in the field of licensing medical activities and the provision of medical services. However, the organizers and sponsors of the events "avoided any responsibility due to gaps in legislation."
We are talking about two decisions of the Moscow Arbitration Court. After receiving the materials from Roszdravnadzor, the prosecutor's office filed a lawsuit against Clovermed LLC, which was the general sponsor of the events, and BIO Concern LLC, which organized the congresses.
Among the violations pointed out by the prosecutor's office was the holding of master classes in conference halls using medical devices for demonstration cosmetic procedures. A doctor from the Chelyabinsk clinic performed a separate cosmetology procedure at the forum site. However, its license is valid only in Chelyabinsk, and not in Moscow. Moreover, the device with which the procedure was performed was not registered in the databases of medical devices.
As a result, the prosecutor's office filed claims against the sponsors and organizers of the exhibition. But the court refused to satisfy the requirements — and not because all these actions were recognized as legitimate, but because there was no evidence that it was the sponsor and organizer who should be responsible for carrying out medical and pharmaceutical activities at these events. The court divided the responsibility — and, in fact, removed it from the responsible persons, without refuting the violations as such (they were not given a legal assessment in the decisions).
Izvestia sent a request to the Moscow City Prosecutor's office asking why lawsuits were addressed specifically to the sponsor and organizer of the event, and not to the companies that directly committed the violations indicated by Roszdravnadzor. No response has been received at the time of publication.
The bill adopted in the first reading will make it possible to hold organizers accountable: all prohibitions are prescribed in Part 4 of Article 79.3 with the preamble "Organizers and participants (their representatives, other individuals and legal entities operating on behalf of these organizations) during the event [...] are not entitled."
How will the bill affect the market
— For conscientious organizers and scientific communities, the procedure will be as simple as possible and in fact will be reduced to confirming compliance with the standards that they already comply with, — Leonid Ogul emphasized. — Close attention will be required to precisely those events that disguise themselves as scientific forums, but in fact are advertising campaigns.
The proposed mechanism for coordination with Roszdravnadzor is not a multi—stage bureaucratic process, but a "spot filter" that will help check whether the event meets the basic criteria, the parliamentarian said. At the same time, by the second reading, one of the authors of the bill promises to finalize the norms so that they do not create barriers to real science.
Anastasia Logova believes that it will be easier for large congresses to adapt to new requirements.: They have legal support, budgets, and the ability to plan their work for the year ahead.
— For small organizers, additional approvals, fees and mandatory publication of information in two months can become a serious burden, — said the interlocutor of Izvestia. — They are often organized by specialists themselves, without a separate administrative team. Additional approvals, mandatory publication of information two months in advance, and fees can make such events economically unprofitable.
According to her, by the second reading, it is important to provide a simplified procedure for small educational events in order to maintain the availability of vocational training in the regions.
It is important to approach this issue with full attention, as regional doctors often gain access to modern technologies through congresses, Alexander Dzidzaria added. And if regulation leads to an increase in the cost of organization and a reduction in the number of events, specialists from the regions will suffer first of all.
Alexander Tkachev, a neurologist and founder of the Tkachev clinic network, also noted that the new requirements could indeed lead to higher prices and a reduction in the number of events. It all depends on how the procedure will be arranged. And if the coordination becomes lengthy and opaque, it is precisely small regional conferences and meetings on narrow specialties that will be at risk.
— Business participation in itself does not make the conference bad: manufacturers participate in research and technology development. The question is whether an independent examination and the opportunity to discuss inconvenient results remain," he said.
Medical congresses and professional forums are important for gaining new knowledge, sharing practical experience, and networking, especially in the context of an imperfect system of continuous professional development in medicine, Olga Shuppo, founder and scientific director of the Grand Clinic network of immunorehabilitation, adaptive and preventive medicine clinics, confirmed. According to her, given that the money allocated by the state for the organization of such forums is not enough, specialized congresses are funded by pharmaceutical manufacturers. It is only important to "define a reasonable line" separating advertising from the scientific expert part of the event.
Victoria Presnyakova clarified that she sees risks not for large scientific congresses, but for narrow-profile companies. At the same time, a much larger volume of hidden advertising passes through social networks, webinars on commercial educational platforms and the work of medical representatives. And the activities in this system remain only the tip of the iceberg, albeit the "most noticeable" one.
"For a real effect, the bill must be synchronized with the amendments to the Federal Law "On Advertising" and the Federal Law "On the Circulation of Medicines" concerning the digital space and the status of medical representatives," concluded the editorial interlocutor.
Izvestia sent inquiries to the Ministry of Health and Roszdravnadzor. No responses had been received at the time of publication.
Переведено сервисом «Яндекс Переводчик»